Bank Of New York Mellon Corp Theravance Biopharma, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$9.65 - $11.34 $2.04 Million - $2.4 Million	211,596 New	211,596 $2.37 Million
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $197,626 - $240,732	23,555 Added 12.95%	205,470 $2.08 Million
Q2 2022 Aug 15, 2022	SELL	$8.41 - $10.34 $65,446 - $80,465	-7,782 Reduced 4.1%	181,915 $1.65 Million
Q1 2022 May 11, 2022	BUY	$8.33 - $12.96 $11,420 - $17,768	1,371 Added 0.73%	189,697 $1.81 Million
Q4 2021 Feb 11, 2022	BUY	$7.42 - $11.05 $88,335 - $131,550	11,905 Added 6.75%	188,326 $2.08 Million
Q3 2021 Nov 12, 2021	BUY	$6.77 - $14.41 $7,189 - $15,303	1,062 Added 0.61%	176,421 $1.31 Million
Q2 2021 Aug 11, 2021	SELL	$14.52 - $22.46 $391,314 - $605,297	-26,950 Reduced 13.32%	175,359 $2.55 Million
Q1 2021 May 13, 2021	SELL	$16.57 - $21.08 $62,485 - $79,492	-3,771 Reduced 1.83%	202,309 $4.13 Million
Q4 2020 Feb 09, 2021	SELL	$14.89 - $20.16 $72,886 - $98,683	-4,895 Reduced 2.32%	206,080 $3.66 Million
Q3 2020 Nov 12, 2020	SELL	$14.79 - $22.49 $64,188 - $97,606	-4,340 Reduced 2.02%	210,975 $3.12 Million
Q2 2020 Aug 12, 2020	BUY	$20.64 - $30.69 $89,722 - $133,409	4,347 Added 2.06%	215,315 $4.52 Million
Q1 2020 May 06, 2020	BUY	$17.84 - $31.21 $135,584 - $237,196	7,600 Added 3.74%	210,968 $4.88 Million
Q4 2019 Feb 14, 2020	BUY	$16.12 - $25.89 $98,283 - $157,851	6,097 Added 3.09%	203,368 $5.27 Million
Q3 2019 Nov 07, 2019	SELL	$16.51 - $23.78 $174,543 - $251,402	-10,572 Reduced 5.09%	197,271 $3.84 Million
Q2 2019 Aug 12, 2019	SELL	$15.6 - $25.15 $21,309 - $34,354	-1,366 Reduced 0.65%	207,843 $3.39 Million
Q1 2019 May 14, 2019	BUY	$22.57 - $28.15 $24,646 - $30,739	1,092 Added 0.52%	209,209 $4.74 Million
Q4 2018 Feb 11, 2019	BUY	$22.52 - $35.07 $57,358 - $89,323	2,547 Added 1.24%	208,117 $5.33 Million
Q3 2018 Nov 09, 2018	SELL	$22.83 - $32.67 $11,871 - $16,988	-520 Reduced 0.25%	205,570 $0
Q2 2018 Aug 06, 2018	SELL	$22.06 - $25.52 $84,203 - $97,409	-3,817 Reduced 1.82%	206,090 $4.67 Million
Q1 2018 May 15, 2018	SELL	$23.37 - $29.71 $18,088 - $22,995	-774 Reduced 0.37%	209,907 $5.09 Million
Q4 2017 Feb 09, 2018	BUY	$25.82 - $35.66 $5.44 Million - $7.51 Million	210,681	210,681 $5.88 Million

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

Madison Avenue Partners, LP New York, NY

9.51M
Shares

$91.2 Million
9.44% of portfolio
Weiss Asset Management LP Boston, MA

7.46M
Shares

$71.5 Million
1.94% of portfolio
Newtyn Management, LLC New York, NY

4.5M
Shares

$43.1 Million
6.4% of portfolio
Black Rock Inc. New York, NY

3.78M
Shares

$36.3 Million
0.0% of portfolio
Irenic Capital Management LP New York, NY

2.76M
Shares

$26.5 Million
1.95% of portfolio

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account